The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and ...

Initiating palliative care more than 3 months before death improves end-of-life outcomes for patients with ovarian cancer, ...

Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...

"I feel like I have a responsibility to scream and shout loudly about it and say 'hey, this is killing women in Australia'," ...

Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

and lab have discovered a new approach to treating ovarian cancer that, in preclinical laboratory testing, shrinks tumors and ...

The following is a summary of “CD1a affects the recurrence and prognosis of ovarian cancer,” published in the November 2024 ...

The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

You have the power to save lives by funding a public awareness campaign which would help women to spot the signs" ...

Penn Ovarian Cancer Research Center and Basser Center for BRCA, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States ...

and lab have discovered a new approach to treating ovarian cancer that, in preclinical laboratory testing, shrinks tumors and improves survival rates while simultaneously making tumors more receptive ...